GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IR-Med Inc (OTCPK:IRME) » Definitions » EV-to-EBITDA

IRME (IR-Med) EV-to-EBITDA : -5.77 (As of May. 21, 2025)


View and export this data going back to 2021. Start your Free Trial

What is IR-Med EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, IR-Med's enterprise value is $8.78 Mil. IR-Med's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.52 Mil. Therefore, IR-Med's EV-to-EBITDA for today is -5.77.

The historical rank and industry rank for IR-Med's EV-to-EBITDA or its related term are showing as below:

IRME' s EV-to-EBITDA Range Over the Past 10 Years
Min: -5.77   Med: 0   Max: 0
Current: -5.77

IRME's EV-to-EBITDA is ranked worse than
100% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 15.615 vs IRME: -5.77

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-21), IR-Med's stock price is $0.12. IR-Med's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.040. Therefore, IR-Med's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


IR-Med EV-to-EBITDA Historical Data

The historical data trend for IR-Med's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IR-Med EV-to-EBITDA Chart

IR-Med Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
- -37.64 -6.71 -16.32 -17.31

IR-Med Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.68 -12.09 -13.03 -17.31 -22.82

Competitive Comparison of IR-Med's EV-to-EBITDA

For the Medical Devices subindustry, IR-Med's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IR-Med's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IR-Med's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where IR-Med's EV-to-EBITDA falls into.


;
;

IR-Med EV-to-EBITDA Calculation

IR-Med's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8.780/-1.521
=-5.77

IR-Med's current Enterprise Value is $8.78 Mil.
IR-Med's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IR-Med  (OTCPK:IRME) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

IR-Med's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.12/-0.040
=At Loss

IR-Med's share price for today is $0.12.
IR-Med's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.040.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


IR-Med EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of IR-Med's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


IR-Med Business Description

Traded in Other Exchanges
N/A
Address
Z.H.R Industrial Zone, P.O. Box 143, Rosh Pina, ISR, 1231400
IR-Med Inc is a development stage medical device company developing its technology through its Subsidiary and is utilizing Infra-Red-light spectroscopy (IR) combined with Artificial Intelligence (AI) technology platform to develop non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time.